249 related articles for article (PubMed ID: 10639424)
1. Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.
Leib SL; Leppert D; Clements J; Täuber MG
Infect Immun; 2000 Feb; 68(2):615-20. PubMed ID: 10639424
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis.
Leib SL; Clements JM; Lindberg RL; Heimgartner C; Loeffler JM; Pfister LA; Täuber MG; Leppert D
Brain; 2001 Sep; 124(Pt 9):1734-42. PubMed ID: 11522576
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae.
Leppert D; Leib SL; Grygar C; Miller KM; Schaad UB; Holländer GA
Clin Infect Dis; 2000 Jul; 31(1):80-4. PubMed ID: 10913401
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase inhibition lowers mortality and brain injury in experimental pneumococcal meningitis.
Liechti FD; Grandgirard D; Leppert D; Leib SL
Infect Immun; 2014 Apr; 82(4):1710-8. PubMed ID: 24491581
[TBL] [Abstract][Full Text] [Related]
5. In pneumococcal meningitis a novel water-soluble inhibitor of matrix metalloproteinases and TNF-alpha converting enzyme attenuates seizures and injury of the cerebral cortex.
Meli DN; Loeffler JM; Baumann P; Neumann U; Buhl T; Leppert D; Leib SL
J Neuroimmunol; 2004 Jun; 151(1-2):6-11. PubMed ID: 15145598
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of GM6001 as an adjuvant to ceftriaxone in a neonatal rat model of Streptococcus pneumoniae meningitis.
Liu X; Han Q
Acta Neurobiol Exp (Wars); 2014; 74(4):489-96. PubMed ID: 25576979
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-9 in pneumococcal meningitis: activation via an oxidative pathway.
Meli DN; Christen S; Leib SL
J Infect Dis; 2003 May; 187(9):1411-5. PubMed ID: 12717622
[TBL] [Abstract][Full Text] [Related]
8. Dexamethasone regulation of matrix metalloproteinase expression in experimental pneumococcal meningitis.
Liu X; Han Q; Sun R; Li Z
Brain Res; 2008 May; 1207():237-43. PubMed ID: 18374903
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of matrix metalloproteinases-2 and -9 prevents cognitive impairment induced by pneumococcal meningitis in Wistar rats.
Barichello T; Generoso JS; Michelon CM; Simões LR; Elias SG; Vuolo F; Comim CM; Dal-Pizzol F; Quevedo J
Exp Biol Med (Maywood); 2014 Feb; 239(2):225-31. PubMed ID: 24419461
[TBL] [Abstract][Full Text] [Related]
10. Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis.
Muri L; Grandgirard D; Buri M; Perny M; Leib SL
J Neuroinflammation; 2018 Aug; 15(1):233. PubMed ID: 30131074
[TBL] [Abstract][Full Text] [Related]
11. Brain parenchymal TNF-α and IL-1β induction in experimental pneumococcal meningitis.
Izadpanah K; Freyer D; Weber JR; Braun JS
J Neuroimmunol; 2014 Nov; 276(1-2):104-11. PubMed ID: 25218213
[TBL] [Abstract][Full Text] [Related]
12. Effects of Toll-like receptor 2 agonist Pam(3)CysSK(4) on inflammation and brain damage in experimental pneumococcal meningitis.
Sellner J; Grandgirard D; Gianinazzi C; Landmann RM; Leib SL
J Neuroimmunol; 2009 Jan; 206(1-2):28-31. PubMed ID: 19012971
[TBL] [Abstract][Full Text] [Related]
13. In bacterial meningitis cortical brain damage is associated with changes in parenchymal MMP-9/TIMP-1 ratio and increased collagen type IV degradation.
Sellner J; Leib SL
Neurobiol Dis; 2006 Mar; 21(3):647-56. PubMed ID: 16257222
[TBL] [Abstract][Full Text] [Related]
14. Nonselective matrix metalloproteinase but not tumor necrosis factor-α inhibition effectively preserves the early critical colon anastomotic integrity.
Ågren MS; Andersen TL; Andersen L; Schiødt CB; Surve V; Andreassen TT; Risteli J; Franzén LE; Delaissé JM; Heegaard AM; Jorgensen LN
Int J Colorectal Dis; 2011 Mar; 26(3):329-37. PubMed ID: 21193914
[TBL] [Abstract][Full Text] [Related]
15. MMPs contribute to TNF-alpha-induced alteration of the blood-cerebrospinal fluid barrier in vitro.
Zeni P; Doepker E; Schulze-Topphoff U; Huewel S; Tenenbaum T; Galla HJ
Am J Physiol Cell Physiol; 2007 Sep; 293(3):C855-64. PubMed ID: 17507431
[TBL] [Abstract][Full Text] [Related]
16. Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis.
Grandgirard D; Schürch C; Cottagnoud P; Leib SL
Antimicrob Agents Chemother; 2007 Jun; 51(6):2173-8. PubMed ID: 17371820
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of tyrosine phosphatase SHP2 in experimental pneumococcal meningitis: correlation with tumor necrosis factor-alpha and cerebrospinal fluid pleocytosis.
Feng M; Sun R; Zhang C; Sun E; Wei S; Wan J; Sun R
J Child Neurol; 2008 Mar; 23(3):287-92. PubMed ID: 18305318
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of matrix metalloproteinase activity prevents increases in myocardial tumor necrosis factor-alpha.
Murray DB; Levick SP; Brower GL; Janicki JS
J Mol Cell Cardiol; 2010 Aug; 49(2):245-50. PubMed ID: 20403361
[TBL] [Abstract][Full Text] [Related]
19. Marked increase of matrix metalloproteinase 9 in cerebrospinal fluid of patients with fungal or tuberculous meningoencephalitis.
Matsuura E; Umehara F; Hashiguchi T; Fujimoto N; Okada Y; Osame M
J Neurol Sci; 2000 Feb; 173(1):45-52. PubMed ID: 10675579
[TBL] [Abstract][Full Text] [Related]
20. Role of metalloproteinases and tissue inhibitors of metalloproteinases during cardiopulmonary bypass in rats.
Guenzinger R; Lahm H; Wottke M; Lange R
ASAIO J; 2012; 58(3):204-11. PubMed ID: 22395114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
